In vitro, CCK‐8 and colony formation assays showed that silencing FADS2 inhibited bladder tumour growth, while migration and scratch assays demonstrated that FADS2 knockdown reduced the migration capacity of bladder cancer cells. This evidence concerns the gene FADS2 and urinary bladder cancer.